CfPIE - The Center for Professional Innovation & Education, Berlin, Germany
26 - 28 March, 2018
Course Description - Course runs 9:00 - 5:00 on Day 1 & Day 2 -- 9:00 - 3:00 on Day 3 (Breakfast & Lunch Included)
The first two days of this course will introduce and detail the basic and intermediate statistical concepts that are essential for professionals in a biological, public health or medical environment. The first day will emphasize the principles of descriptive and inferential statistical applications while the second day will focus on actual study examples, problem solving and interpretation of clinical (efficacy and adverse events) results. Throughout the course, participants are encouraged to ask questions and discuss examples relevant to their own work.
The following include but are not limited to topic areas to be discussed:
- Basic statistical terminology needed to effectively communicate with and understand your statistical colleagues
- The statistical essentials required to initiate a research investigation and plan a clinical trial
- Research questions in statistical terms and bias reducing techniques in planning a clinical trial
- Sample size considerations to insure accuracy of conclusions in clinical trials to determine treatment efficacy. A discussion of ethical considerations in sample size planning
- Examination of Phase I (adverse events) and dose response studies
- Discussion of statistical techniques to compare experimental approaches or treatment efficacy with a focus on superiority outcomes
- An introduction to interim and group sequential designs as well as futility analysis
The third day of course will cover more complex issues in research investigations and clinical trials. Topics will include:
- Association studies including correlation and regression analysis with clinical applications to multiple intervention strategies
- Examination of Phase II and III clinical trials analysis. Comparative studies will contrast superiority, equivalence and non -inferiority approaches to design and analysis
- Survival analysis and discussion of related techniques (hazard ratio, multivariate Cox modeling)
- Gaining information from multiple studies by meta-analysis and the challenges of combining information
Who Should Attend
This three-day course is designed as an introduction to the statistical principles that form the basis for the design and analysis of research investigations in pharmaceutical and medical device studies. The focus of topics will benefit individuals within the pharmaceutical, biotech and device industries including R&D managers, medical investigators, basic and clinical research scientists, clinical research associates and those involved in regulatory affairs.
The course will concentrate on the philosophy and understanding of the statistical principles required in conducting sound scientific investigations with an interdisciplinary approach to trial design and analysis. It includes discussion of the topics one considers in the Statistical Analysis Plan (SAP). It will not simply present statistical formulae. Thus, the lectures are oriented toward professionals having little or no formal training in statistics or mathematics.
Al Bartolucci, Ph.D.
Al Bartolucci, Ph.D.
Dr. Al Bartolucci is Emeritus Professor of Biostatistics at the University of Alabama where he also serves as a Senior Scientist at the Center for Metabolic Bone Diseases, AIDS Research Center and Cancer Center.
He previously served as Chairman of the Department from 1984 through 1997. He has also taught Statistical Software courses involving Data Exploration, ANOVA/Regression and Design of Experiments. His teaching experience includes areas such as, Clinical Trials, Survival Analysis, Multivariate Analysis, Regression Techniques and Environmental/Industrial Hygiene Sampling and Analysis, Bayesian Statistics, and Longitudinal Data Analysis.
Dr. Bartolucci received his PhD in Statistics from the State University of New York at Buffalo and his MA in Mathematics from Catholic University, Washington DC, and his BA in Mathematics from Holy Cross.